100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Metoprolol Succinate 47.5mg (Metoprolol Tartrate 50mg) + Olmesartan Medoxomil 20mg
Our Recommendation
Olmekem 20/50mg M Tablet ER 10s
120+ trust this
WHO GMP Certified


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Delivery by
In Hypertension (high blood pressure)Omten-M 50 Tablet ER is a combination medicine that contains two active ingredients, Amlodipine and Metoprolol Succinate. Both of the medicines in this combination work to lower blood pressure but in different ways. Together they help to relax blood vessels, reduce heart rate and make it easier for your heart to pump blood around your body. This lowers blood pressure. If your blood pressure is controlled you are less at risk of having a heart attack, stroke or kidney problems. The medicine must be taken regularly as prescribed to be effective. You do not usually feel any direct benefit from taking this medicine, but it works in the long term to keep you well. You should also make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine.
Side effects of Omten-M Tablet ERThe majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Omten-MNausea Diarrhea Constipation Upset stomach Taste change Weakness Dizziness Headache Cold extremities Increased potassium level in blood Numbness of extremity Slow heart rate Decreased blood pressure Orthostatic hypotension (sudden lowering of blood pressure on standing)Breathlessness Abdominal pain
How to use Omten-M Tablet ERFollow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Omten-M 50 Tablet ER is to be taken with food.
How Omten-M Tablet ER works Omten-M 50 Tablet ER is a combination of two blood-pressure lowering medicines: Olmesartan Medoxomil and Metoprolol Succinate.
Unsafe: Avoid consuming alcohol with Omten-M 50 Tablet ER as it is deemed unsafe.
Omten-M 50 Tablet ER is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Omten-M 50 Tablet ER is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Omten-M 50 Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Omten-M 50 Tablet ER should be used with caution in patients with severe kidney disease. Dose adjustment of Omten-M 50 Tablet ER may be needed. Doctor consultation is advised.Regular monitoring of blood pressure is advisable for dose adjustment.
Omten-M 50 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Omten-M 50 Tablet ER may be needed. Doctor consultation is advised.
If a dose of Omten-M 50 Tablet ER is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
42/44, Babu Genu Road, Shop No. 06, 2nd Floor, Om Shanti Co-op Housing Society, Kalbadevi Road, Mumbai-400002. (India)
Olmesartan medoxomil. Parsippany, New Jersey: Daiichi Sankyo, Inc.; 2009 (11 Apr. 2019)
Metoprolol succinate. Södertälje, Sweden: AstraZeneca AB; 1992 (11 Apr. 2019)
Drugs.com. Metoprolol Succinate (11 Apr. 2019)
Olmesartan Medoxomil & Metoprolol Succinate ER (28th Sept. 2023)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.